Immunotherapy in Early-Stage Lung Cancer
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, interviews Patrick Forde, MD (MB, BCh), at the 2022 AACR meeting (April 12, 2022).
University of Michigan ALK Positive Webinar
Amy Moore, PhD, LUNGevity's Vice President, Global Engagement and Patient Partnerships, conducts this webinar on ALK-positive lung cancer.
Acquired Resistance Q&A
Drs. Gregory Riely, Jared Weiss, and Lecia Sequist sat for a Q&A with Dr. Jack West at the Acquired Resistance in Lung Cancer Patient Forum
Acquired Resistance Roundtable
Roundtable discussion of acquired resistance to lung cancer therapies featuring Drs. Sequist and Riely
BRAF and Other RAF Mutations
Dr. Charles Rudin explains BRAF and other RAF mutations, their role with KRAS, and how they are being studied in clinical trials
Lung Cancer Histology
Dr. Cathy Pietanza explains the differences between small cell and non-small cell lung cancer
Dr. Joel Neal talks about whether patients with early-stage lung cancer should get their tumor tested for mutations